References
1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature.
2002;415(6868):219-26.
2. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial
fibrillation: mechanisms and implications. Circulation: Arrhythmia and
Electrophysiology. 2008;1(1):62-73.
3. Lip GY, Tse H-F. Management of atrial fibrillation. The Lancet.
2007;370(9587):604-18.
4. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific
cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150-61.
5. Association DwtscotEHR, Surgery EbtEAfC-T, Members ATF, Camm AJ,
Kirchhof P, Lip GY, et al. Guidelines for the management of atrial
fibrillation: the Task Force for the Management of Atrial Fibrillation
of the European Society of Cardiology (ESC). European heart journal.
2010;31(19):2369-429.
6. A Comparison of Rate Control and Rhythm Control in Patients with
Atrial Fibrillation. New England Journal of Medicine.
2002;347(23):1825-33.
7. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al.
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New
England Journal of Medicine. 2020;383(14):1305-16.
8. Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J,
et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial
Fibrillation. New England Journal of Medicine. 2020;384(4):305-15.
9. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens
L, et al. Catheter ablation for atrial fibrillation with heart failure.
New England Journal of Medicine. 2018;378(5):417-27.
10. Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM,
Bergfeldt L, Kennebäck G, et al. Effect of catheter ablation vs
antiarrhythmic medication on quality of life in patients with atrial
fibrillation: the CAPTAF randomized clinical trial. Jama.
2019;321(11):1059-68.
11. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B,
Vasavakul T, et al. A new approach for catheter ablation of atrial
fibrillation: mapping of the electrophysiologic substrate. Journal of
the American College of Cardiology. 2004;43(11):2044-53.
12. Spencer K, Mor-Avi V, Gorcsan Jr, DeMaria A, Kimball T, Monaghan M,
et al. Effects of aging on left atrial reservoir, conduit, and booster
pump function: a multi-institution acoustic quantification study. Heart.
2001;85(3):272-7.
13. Heppell R, Berkin K, McLenachan J, Davies J. Haemostatic and
haemodynamic abnormalities associated with left atrial thrombosis in
non-rheumatic atrial fibrillation. Heart. 1997;77(5):407-11.
14. Al-Saady N, Obel O, Camm A. Left atrial appendage: structure,
function, and role in thromboembolism. Heart. 1999;82(5):547-54.
15. Barbero U, Ho SY. Anatomy of the atria. Herzschrittmachertherapie +
Elektrophysiologie. 2017;28(4):347-54.
16. Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A. Left
atrial appendage studied by computed tomography to help planning for
appendage closure device placement. Journal of cardiovascular
electrophysiology. 2010;21(9):973-82.
17. Chava R, Turagam MK, Lakkireddy DD. Left Atrial Appendage Occlusion:
What Are the Options and Where is the Evidence? J Innov Card Rhythm
Manag. 2018;9(4):3095-106.
18. Marrouche NF, Greene T, Dean JM, Kholmovski EG, Boer LMd, Mansour M,
et al. Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional
catheter ablation of atrial fibrillation: The DECAAF II trial: Study
design. Journal of cardiovascular electrophysiology. 2021;32(4):916-24.
19. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F,
et al. Association of Atrial Tissue Fibrosis Identified by Delayed
Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF
Study. JAMA. 2014;311(5):498-506.
20. Masci A, Barone L, Dedè L, Fedele M, Tomasi C, Quarteroni A, et al.
The Impact of Left Atrium Appendage Morphology on Stroke Risk Assessment
in Atrial Fibrillation: A Computational Fluid Dynamics Study. Frontiers
in Physiology. 2019;9(1938).
21. Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ,
et al. Usefulness of Left Atrial Volume in Predicting First Congestive
Heart Failure in Patients ≥65 Years of Age With Well-Preserved Left
Ventricular Systolic Function. The American Journal of Cardiology.
2005;96(6):832-6.
22. Dernellis JM, Stefanadis CI, Zacharoulis AA, Toutouzas PK. Left
atrial mechanical adaptation to long-standing hemodynamic loads based on
pressure–volume relations. The American journal of cardiology.
1998;81(9):1138-43.
23. Bakalli A, Kamberi L, Pllana E, Zahiti B, Dragusha G, Brovina A. The
influence of left ventricular diameter on left atrial appendage size and
thrombus formation in patients with dilated cardiomyopathy. Turk
Kardiyol Dern Ars. 2010;38(2):90-4.
24. Xu Y, Zhao L, Zhang L, Han Y, Wang P, Yu S. Left Atrial Enlargement
and the Risk of Stroke: A Meta-Analysis of Prospective Cohort Studies.
Front Neurol. 2020;11:26-.
25. Taina M, Vanninen R, Hedman M, Jäkälä P, Kärkkäinen S, Tapiola T, et
al. Left Atrial Appendage Volume Increased in More Than Half of Patients
with Cryptogenic Stroke. PLOS ONE. 2013;8(11):e79519.
26. Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili
S, et al. Does the left atrial appendage morphology correlate with the
risk of stroke in patients with atrial fibrillation? Results from a
multicenter study. Journal of the American College of Cardiology.
2012;60(6):531-8.
27. Korhonen M, Muuronen A, Arponen O, Mustonen P, Hedman M, Jäkälä P,
et al. Left atrial appendage morphology in patients with suspected
cardiogenic stroke without known atrial fibrillation. PLoS One.
2015;10(3):e0118822.
28. Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T,
Nishiyama N, et al. Anatomical characteristics of the left atrial
appendage in cardiogenic stroke with low CHADS2 scores. Heart Rhythm.
2013;10(6):921-5.
29. Lupercio F, Ruiz JC, Briceno DF, Romero J, Villablanca PA, Berardi
C, et al. Left atrial appendage morphology assessment for risk
stratification of embolic stroke in patients with atrial fibrillation: a
meta-analysis. Heart Rhythm. 2016;13(7):1402-9.
30. Khurram IM, Dewire J, Mager M, Maqbool F, Zimmerman SL, Zipunnikov
V, et al. Relationship between left atrial appendage morphology and
stroke in patients with atrial fibrillation. Heart rhythm.
2013;10(12):1843-9.
31. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA.
Estimation of left ventricular filling pressures using two-dimensional
and Doppler echocardiography in adult patients with cardiac disease:
additional value of analyzing left atrial size, left atrial ejection
fraction and the difference in duration of pulmonary venous and mitral
flow velocity at atrial contraction. Journal of the American College of
Cardiology. 1993;22(7):1972-82.
32. Yamada A, Hashimoto N, Fujito H, Hatta T, Saito Y, Otsuka N, et al.
Comprehensive assessment of left atrial and ventricular remodeling in
paroxysmal atrial fibrillation by the cardiovascular magnetic resonance
myocardial extracellular volume fraction and feature tracking strain.
Scientific reports. 2021;11(1):1-12.
33. Donal E, Yamada H, Leclercq C, Herpin D. The left atrial appendage,
a small, blind-ended structure: a review of its echocardiographic
evaluation and its clinical role. Chest. 2005;128(3):1853-62.
34. Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left
atrial appendage: anatomy, function, and noninvasive evaluation. JACC:
Cardiovascular imaging. 2014;7(12):1251-65.
35. Cha Y-M, Redfield MM, Shen W-K, Gersh BJ. Atrial Fibrillation and
Ventricular Dysfunction. Circulation. 2004;109(23):2839-43.
36. Lee JM, Shim J, Uhm J-S, Kim YJ, Lee H-J, Pak H-N, et al. Impact of
Increased Orifice Size and Decreased Flow Velocity of Left Atrial
Appendage on Stroke in Nonvalvular Atrial Fibrillation. American Journal
of Cardiology. 2014;113(6):963-9.
37. Syed FF, DeSimone CV, Friedman PA, Asirvatham SJ. Left atrial
appendage exclusion for atrial fibrillation. Cardiol Clin.
2014;32(4):601-25.